top of page
AdobeStock_237330799 (1).jpeg

We are on a mission to address the most challenging and unaddressed diseases impacting humankind.

PulmoSIM%20Tx_Image%20with%20overlay_3_e

ABOUT

PulmoSIM Therapeutics is the pharmaceutical brand of VeriSIM Life, developing breakthrough therapies for rare and progressive respiratory diseases to improve patient outcomes and quality of life. Our immediate focus is to address the unmet needs in pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF) by targeting the underlying biology to alleviate the need for combination therapies.


We leverage BIOiSIM, a first-in-class artificial intelligence bio-simulation platform developed by VeriSIM Life, to accelerate our drug development by bridging the translational gap between preclinical and clinical phases.

ABOUT

PIPELINE

Pipeline yellow.png
PIPELINE
Jo%20Varshney%20new%20overlay_edited.jpg

Dr. Jo Varshney DVM, Ph.D.

CEO & Founder

Dr. Vivek Gupta_overlay.jpg

Dr. Vivek Gupta, Ph.D.

Scientific Founder

Dr. Eva S. Nozik_overlay.jpg
Dr. Samir Mitragotri_overlay.jpg

Dr. Samir Mitragotri, Ph.D.

Strategic Advisor

Dr. Hugh Smyth_overlay.jpg

Dr. Hugh Smyth, Ph.D.

Strategic Advisor

screenshot-www_verisimlife_com-2024_11_13-15_21_14_edited.jpg

Gordon Murtaugh,

VP Corporate Development

TEAM & ADVISORY BOARD

TEAM

Dr. Eva S. Nozik, MD

Strategic Advisor

AdobeStock_636263973.jpeg

PRESS & NEWS

PRESS & EVENTS
CONTACT
AdobeStock_617436262.jpeg

INTERESTED IN PARTNERING WITH US?

Thanks for submitting!

  • Black LinkedIn Icon
bottom of page